Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|4|6|871-886

ISSN: 2045-7634

Source: Cancer Medicine, Vol.4, Iss.6, 2015-06, pp. : 871-886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content